Human Herpes Virus-6 Encephalitis Following Autologous Blood and Marrow Transplant [0.03%]
自体血液和骨髓移植后的人类 herpes virus-6脑炎
Jacques Mario Azzi,Doyun Park,Maher Abdul-Hay et al.
Jacques Mario Azzi et al.
Human herpesvirus-6 (HHV-6) is a highly prevalent virus that establishes lifelong latency in human hosts. Symptomatic HHV-6 reactivation rarely occurs in immunocompetent individuals and is best described in immunosuppressed patients such as...
Clinical Advancement and Challenges of ex vivo Expansion of Human Cord Blood Cells [0.03%]
人脐血细胞体外扩增的临床进展与挑战
Oluwadunni E Emiloju,Rashmika Potdar,Vinicius Jorge et al.
Oluwadunni E Emiloju et al.
Apart from peripheral blood stem cell (PBSC), umbilical cord blood (UCB) is now a recognized source of stem cells for transplantation. UCB is an especially important source of stem cells for minority populations, which would otherwise be un...
Jonathan Canaani
Jonathan Canaani
Despite considerable advances in our understanding of the molecular and epigenetic underpinnings of the myelodysplastic syndromes (MDS), this diverse group of myeloid neoplasms remains a significant clinical challenge. Considerable barriers...
Current Status and Future Directions in Graft- Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults [0.03%]
成人异体血液和骨髓移植后移植物抗宿主病预防的现状与未来方向
Cosmin Tegla,Jun Choi,Maher Abdul-Hay et al.
Cosmin Tegla et al.
Graft-versus-host disease (GvHD) in its acute and chronic forms continues to represent a significant barrier to the success and wide-applicability of blood and marrow transplantation as a potentially curative treatment modality for a number...
Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation [0.03%]
血液细胞移植观察和登记研究的科学统计方法，研究终点和定义总结
Abraham S Kanate,Arnon Nagler,Bipin Savani
Abraham S Kanate
Due to the increasingly strict word/character restrictions enforced by most scientific publications, we identified a need for a master document illustrating the "Scientific Methods" that may be applicable to the majority of observational an...
Mohamad Mohty,Arnon Nagler,Bipin Savani
Mohamad Mohty
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation [0.03%]
生物类似物粒细胞集落刺激因子在自体和异基因造血干细胞移植动员中的应用
Dwight D Eplin,Anna D Jackson,Austin M Smith et al.
Dwight D Eplin et al.
The biologic medication filgrastim is approved by the Food and Drug Administration (FDA) to mobilize hematopoietic progenitor cells (HPCs) for collection by leukapheresis for autologous hematopoietic stem cell transplant (HSCT). The FDA-app...
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study [0.03%]
新型药物时代多发性骨髓瘤的临床经过：一项单中心回顾性的现实世界研究
Agoston Gyula Szabo,Katrine Fladeland Iversen,Sören Möller et al.
Agoston Gyula Szabo et al.
In this retrospective study we reviewed the clinical course of every patient with multiple myeloma treated from 2006 to 2016 at Vejle Hospital: 303 patients with a median age of 69 years at diagnosis received a median of four (range 1-18) l...
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma [0.03%]
新型诱导治疗及自体干细胞移植克服肾功能损害对多发性骨髓瘤的不利影响
Lalit Kumar,Santosh Kumar Chellapuram,Ramavat Dev et al.
Lalit Kumar et al.
We investigated the impact of renal impairment (RI) on the outcome in multiple myeloma (MM) patients following induction and autologous stem cell transplantation (ASCT). Among 349 patients who received a first ASCT for MM, 86 (24.6%) had RI...
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation [0.03%]
异基因造血细胞移植受者血清半乳糖凝集素-3浓度升高
Zachariah DeFilipp,Nalu Navarro-Alvarez,Shuli Li et al.
Zachariah DeFilipp et al.
Galectin-3 is a beta-galactoside-binding lectin with an established association to inflammatory and fibrotic conditions. We investigated galectin-3 levels in 68 recipients of allogeneic hematopoietic cell transplantation (HCT) to look for a...